Logo image of GBLB.BR

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Stock Fundamental Analysis

Europe - EBR:GBLB - BE0003797140 - Common Stock

73.95 EUR
+1.1 (+1.51%)
Last: 11/11/2025, 5:29:03 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GBLB. GBLB was compared to 50 industry peers in the Financial Services industry. Both the profitability and the financial health of GBLB get a neutral evaluation. Nothing too spectacular is happening here. GBLB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

GBLB had positive earnings in the past year.
GBLB had a positive operating cash flow in the past year.
GBLB had positive earnings in 4 of the past 5 years.
GBLB had a positive operating cash flow in each of the past 5 years.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

1.2 Ratios

GBLB's Return On Assets of 0.52% is in line compared to the rest of the industry. GBLB outperforms 42.00% of its industry peers.
The Return On Equity of GBLB (1.07%) is comparable to the rest of the industry.
GBLB has a worse Return On Invested Capital (0.96%) than 62.00% of its industry peers.
GBLB had an Average Return On Invested Capital over the past 3 years of 0.81%. This is significantly below the industry average of 9.72%.
The 3 year average ROIC (0.81%) for GBLB is below the current ROIC(0.96%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.52%
ROE 1.07%
ROIC 0.96%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

With a Profit Margin value of 1.98%, GBLB perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
GBLB's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 5.49%, GBLB is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
GBLB's Operating Margin has declined in the last couple of years.
GBLB has a better Gross Margin (62.71%) than 68.00% of its industry peers.
GBLB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.49%
PM (TTM) 1.98%
GM 62.71%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

GBLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GBLB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, GBLB has less shares outstanding
The debt/assets ratio for GBLB is higher compared to a year ago.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

GBLB has an Altman-Z score of 1.30. This is a bad value and indicates that GBLB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.30, GBLB is in line with its industry, outperforming 42.00% of the companies in the same industry.
The Debt to FCF ratio of GBLB is 12.98, which is on the high side as it means it would take GBLB, 12.98 years of fcf income to pay off all of its debts.
GBLB has a Debt to FCF ratio (12.98) which is comparable to the rest of the industry.
GBLB has a Debt/Equity ratio of 0.51. This is a neutral value indicating GBLB is somewhat dependend on debt financing.
GBLB has a Debt to Equity ratio (0.51) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 12.98
Altman-Z 1.3
ROIC/WACC0.15
WACC6.23%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GBLB has a Current Ratio of 1.91. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
GBLB has a Current ratio of 1.91. This is in the better half of the industry: GBLB outperforms 70.00% of its industry peers.
A Quick Ratio of 1.56 indicates that GBLB should not have too much problems paying its short term obligations.
GBLB's Quick ratio of 1.56 is fine compared to the rest of the industry. GBLB outperforms 68.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.56
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

GBLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.95%.
The earnings per share for GBLB have been decreasing by -26.51% on average. This is quite bad
The Revenue has decreased by -1.53% in the past year.
The Revenue has been growing slightly by 3.51% on average over the past years.
EPS 1Y (TTM)-91.95%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-83.53%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-5.29%

3.2 Future

Based on estimates for the next years, GBLB will show a decrease in Earnings Per Share. The EPS will decrease by -6.19% on average per year.
The Revenue is expected to grow by 2.33% on average over the next years.
EPS Next Y-28.35%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
EPS Next 5YN/A
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

GBLB is valuated quite expensively with a Price/Earnings ratio of 77.03.
GBLB's Price/Earnings ratio is a bit more expensive when compared to the industry. GBLB is more expensive than 64.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.28. GBLB is valued rather expensively when compared to this.
GBLB is valuated rather expensively with a Price/Forward Earnings ratio of 21.17.
GBLB's Price/Forward Earnings is on the same level as the industry average.
GBLB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 77.03
Fwd PE 21.17
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBLB indicates a somewhat cheap valuation: GBLB is cheaper than 66.00% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as GBLB.
Industry RankSector Rank
P/FCF 16.72
EV/EBITDA 12.75
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

GBLB's earnings are expected to decrease with -6.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.61%, GBLB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.47, GBLB pays a better dividend. On top of this GBLB pays more dividend than 84.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, GBLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.61%

5.2 History

The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years1
Div Non Decr Years4
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

GBLB pays out 468.18% of its income as dividend. This is not a sustainable payout ratio.
GBLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP468.18%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B
GBLB.BR Dividend Payout.GBLB.BR Dividend Payout, showing the Payout Ratio.GBLB.BR Dividend Payout.PayoutRetained Earnings

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (11/11/2025, 5:29:03 PM)

73.95

+1.1 (+1.51%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-12 2026-03-12
Inst Owners25.81%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap9.85B
Revenue(TTM)6.68B
Net Income(TTM)132.30M
Analysts83.08
Price Target87.84 (18.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.61%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP468.18%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.76%
PT rev (3m)1.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 77.03
Fwd PE 21.17
P/S 1.47
P/FCF 16.72
P/OCF 8.17
P/B 0.8
P/tB 1.87
EV/EBITDA 12.75
EPS(TTM)0.96
EY1.3%
EPS(NY)3.49
Fwd EY4.72%
FCF(TTM)4.42
FCFY5.98%
OCF(TTM)9.05
OCFY12.23%
SpS50.19
BVpS92.77
TBVpS39.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.76
Profitability
Industry RankSector Rank
ROA 0.52%
ROE 1.07%
ROCE 1.63%
ROIC 0.96%
ROICexc 1.13%
ROICexgc 1.79%
OM 5.49%
PM (TTM) 1.98%
GM 62.71%
FCFM 8.81%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
ROICexc(3y)0.92%
ROICexc(5y)1.25%
ROICexgc(3y)1.32%
ROICexgc(5y)1.66%
ROCE(3y)1.37%
ROCE(5y)1.91%
ROICexgc growth 3Y-6.63%
ROICexgc growth 5Y-8.4%
ROICexc growth 3Y-11.16%
ROICexc growth 5Y-11.6%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 12.98
Debt/EBITDA 6.63
Cap/Depr 104.99%
Cap/Sales 9.21%
Interest Coverage 0.96
Cash Conversion 126.32%
Profit Quality 445.28%
Current Ratio 1.91
Quick Ratio 1.56
Altman-Z 1.3
F-Score5
WACC6.23%
ROIC/WACC0.15
Cap/Depr(3y)97.68%
Cap/Depr(5y)87.97%
Cap/Sales(3y)10%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.95%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-83.53%
EPS Next Y-28.35%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-5.29%
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A
EBIT growth 1Y-41.9%
EBIT growth 3Y-19.25%
EBIT growth 5Y-15.81%
EBIT Next Year9.24%
EBIT Next 3Y5.06%
EBIT Next 5YN/A
FCF growth 1Y82.78%
FCF growth 3Y8.34%
FCF growth 5Y2.47%
OCF growth 1Y13.85%
OCF growth 3Y8.48%
OCF growth 5Y4.55%

GROUPE BRUXELLES LAMBERT NV / GBLB.BR FAQ

What is the ChartMill fundamental rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GBLB.BR.


What is the valuation status of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to GROUPE BRUXELLES LAMBERT NV (GBLB.BR). This can be considered as Overvalued.


What is the profitability of GBLB stock?

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) has a profitability rating of 4 / 10.


What are the PE and PB ratios of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

The Price/Earnings (PE) ratio for GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 77.03 and the Price/Book (PB) ratio is 0.8.


How financially healthy is GROUPE BRUXELLES LAMBERT NV?

The financial health rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 4 / 10.